# Gemfibrozil for Nicotine Smoking Cessation

> **NCT02638597** · PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 16 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Gemfibrozil
- **BEHAVIORAL:** smoking cessation counseling

## Key facts

- **NCT ID:** NCT02638597
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-12-23
- **Final completion:** 2016-12-23
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02638597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02638597, "Gemfibrozil for Nicotine Smoking Cessation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02638597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*